THE TUMOR IMMUNE MICROENVIRONMENT AS A KEY DETERMINANT OF DISEASE PROGRESSION AND THERAPEUTIC RESPONSE IN HPV-ASSOCIATED CERVICAL CANCER. PSSIR 2026, 3 (1), 11-13.